1. Kumar N, Raghavendra M, Tokas J, Singal HR. Flavor addition in dairy products: health benefits and risks. Watson RR, Cllier RJ, Preedy VR. Nutrients in dairy and their implications on health and disease. Cambridge: Academic Press;2018. p. 123–135.
2. Rondanelli M, Faliva MA, Perna S, Giacosa A, Peroni G, Castellazzi AM. Using probiotics in clinical practice: where are we now? A review of existing meta-analyses. Gut Microbes. 2017; 8:521–543.
![crossref](/image/icon/bnr_ref_cross.gif)
3. Sánchez B, Delgado S, Blanco-Míguez A, Lourenço A, Gueimonde M, Margolles A. Probiotics, gut microbiota, and their influence on host health and disease. Mol Nutr Food Res. 2017; 61:201600240.
![crossref](/image/icon/bnr_ref_cross.gif)
4. Beuchat LR, Kim H, Gurtler JB, Lin LC, Ryu JH, Richards GM. Cronobacter sakazakii in foods and factors affecting its survival, growth, and inactivation. Int J Food Microbiol. 2009; 136:204–213.
![crossref](/image/icon/bnr_ref_cross.gif)
5. Bowen AB, Braden CR. Invasive Enterobacter sakazakii disease in infants. Emerg Infect Dis. 2006; 12:1185–1189.
6. Forsythe SJ. Enterobacter sakazakii and other bacteria in powdered infant milk formula. Matern Child Nutr. 2005; 1:44–50.
![crossref](/image/icon/bnr_ref_cross.gif)
7. Umeda NS, de Filippis I, Forsythe SJ, Brandão ML. Phenotypic characterization of Cronobacter spp. strains isolated from foods and clinical specimens in Brazil. Food Res Int. 2017; 102:61–67.
![crossref](/image/icon/bnr_ref_cross.gif)
8. Osaili T, Forsythe S. Desiccation resistance and persistence of Cronobacter species in infant formula. Int J Food Microbiol. 2009; 136:214–220.
![crossref](/image/icon/bnr_ref_cross.gif)
9. Singh N, Goel G, Raghav M. Insights into virulence factors determining the pathogenicity of Cronobacter sakazakii. Virulence. 2015; 6:433–440.
![crossref](/image/icon/bnr_ref_cross.gif)
10. Singh N, Patil A, Prabhune AA, Raghav M, Goel G. Diverse profiles of N-acyl-homoserine lactones in biofilm forming strains of Cronobacter sakazakii. Virulence. 2017; 8:275–281.
![crossref](/image/icon/bnr_ref_cross.gif)
11. Singh N, Raghav M, Narula S, Tandon S, Goel G. Profiling of virulence determinants in Cronobacter sakazakii isolates from different plant and environmental commodities. Curr Microbiol. 2017; 74:560–565.
![crossref](/image/icon/bnr_ref_cross.gif)
12. Collado MC, Isolauri E, Salminen S. Specific probiotic strains and their combinations counteract adhesion of Enterobacter sakazakii to intestinal mucus. FEMS Microbiol Lett. 2008; 285:58–64.
![crossref](/image/icon/bnr_ref_cross.gif)
13. Sharma G, Prakash A. Susceptibility of Cronobacter sakazakii to plant products, antibiotics, and to lactic acid bacteria. Int J Nutr Pharmacol Neurol Dis. 2013; 3:263–268.
![crossref](/image/icon/bnr_ref_cross.gif)
14. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 27th ed. CLSI supplement M100. Wayne: CLSI;2017.
15. European Food Safety Authority (EFSA). Technical guidance: update of the criteria used in the assessment of bacterial resistance to antibiotics of human or veterinary importance. EFSA J. 2008; 6:732.
16. Singh N, Patil A, Prabhune A, Goel G. Inhibition of quorumsensing-mediated biofilm formation in Cronobacter sakazakii strains. Microbiology. 2016; 162:1708–1714.
![crossref](/image/icon/bnr_ref_cross.gif)
17. Iversen C, Forsythe S. Isolation of Enterobacter sakazakii and other Enterobacteriaceae from powdered infant formula milk and related products. Food Microbiol. 2004; 21:771–777.
![crossref](/image/icon/bnr_ref_cross.gif)
18. Lehner A, Riedel K, Eberl L, Breeuwer P, Diep B, Stephan R. Biofilm formation, extracellular polysaccharide production, and cell-to-cell signaling in various Enterobacter sakazakii strains: aspects promoting environmental persistence. J Food Prot. 2005; 68:2287–2294.
![crossref](/image/icon/bnr_ref_cross.gif)
19. Kim H, Ryu JH, Beuchat LR. Attachment of and biofilm formation by Enterobacter sakazakii on stainless steel and enteral feeding tubes. Appl Environ Microbiol. 2006; 72:5846–5856.
![crossref](/image/icon/bnr_ref_cross.gif)
20. Georgieva R, Yocheva L, Tserovska L, et al. Antimicrobial activity and antibiotic susceptibility of Lactobacillus and Bifidobacterium spp. intended for use as starter and probiotic cultures. Biotechnol Biotechnol Equip. 2015; 29:84–91.
![crossref](/image/icon/bnr_ref_cross.gif)
21. Neut C, Mahieux S, Dubreuil LJ. Antibiotic susceptibility of probiotic strains: is it reasonable to combine probiotics with antibiotics? Med Mal Infect. 2017; 47:477–483.
![crossref](/image/icon/bnr_ref_cross.gif)
22. Shokri D, Khorasgani MR, Mohkam M, Fatemi SM, Ghasemi Y, Taheri-Kafrani A. The inhibition effect of Lactobacilli against growth and biofilm formation of Pseudomonas aeruginosa. Probiotics Antimicrob Proteins. 2018; 10:34–42.
![crossref](/image/icon/bnr_ref_cross.gif)
23. Kivanc M, Yilmaz M, Cakir E. Isolation and identification of lactic acid bacteria from boza, and their microbial activity against several reporter strains. Turk J Biol. 2011; 35:313–324.
24. Denkova RS, Yanakieva VB, Denkova ZR, Hristozova P. Inhibitory activity of the probiotic strain Bifidobacterium bifidum Bif. 4 of human origin against pathogens. J Food Packag Sci Tech Technol. 2013; (2):21–25.
25. Hayes M, Barrett E, Ross RP, Fitzgerald GF, Hill C, Stanton C. Evaluation of an antimicrobial ingredient prepared from a Lactobacillus acidophilus casein fermentate against Enterobacter sakazakii. J Food Prot. 2009; 72:340–346.
![crossref](/image/icon/bnr_ref_cross.gif)
26. Awaisheh SS, Al-Nabulsi AA, Osaili TM, Ibrahim S, Holley R. Inhibition of Cronobacter sakazakii by heat labile bacteriocins produced by probiotic LAB isolated from healthy infants. J Food Sci. 2013; 78:M1416–M1420.
27. Kim DH, Jeong D, Song KY, Kang IB, Kim H, Seo KH. Culture supernatant produced by Lactobacillus kefiri from kefir inhibits the growth of Cronobacter sakazakii. J Dairy Res. 2018; 85:98–103.
![crossref](/image/icon/bnr_ref_cross.gif)
28. Yi L, Dang Y, Wu J, et al. Purification and characterization of a novel bacteriocin produced by Lactobacillus crustorum MN047 isolated from koumiss from Xinjiang, China. J Dairy Sci. 2016; 99:7002–7015.
![crossref](/image/icon/bnr_ref_cross.gif)
29. Drenkard E, Ausubel FM. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature. 2002; 416:740–743.
![crossref](/image/icon/bnr_ref_cross.gif)
30. François ZN, Marie KP, Noëlle TA, Emeric GW. Antimicrobial activity of a bacteriocin produced by Lactobacillus plantarum 29V and strain’s viability in palm kernel oil. Int J Nutr Food Sci. 2013; 2:102–108.
![crossref](/image/icon/bnr_ref_cross.gif)
31. Rao KP, Chennappa G, Suraj U, Nagaraja H, Raj AP, Sreenivasa MY. Probiotic potential of lactobacillus strains isolated from sorghum-based traditional fermented food. Probiotics Antimicrob Proteins. 2015; 7:146–156.
![crossref](/image/icon/bnr_ref_cross.gif)
32. Schaffer AC, Lee JC. Vaccination and passive immunisation against Staphylococcus aureus. Int J Antimicrob Agents. 2008; 32 Suppl 1:S71–S78.
![crossref](/image/icon/bnr_ref_cross.gif)
33. Saravanakumari P, Mani K. Structural characterization of a novel xylolipid biosurfactant from Lactococcus lactis and analysis of antibacterial activity against multi-drug resistant pathogens. Bioresour Technol. 2010; 101:8851–8854.
![crossref](/image/icon/bnr_ref_cross.gif)
34. Shokouhfard M, Kermanshahi RK, Shahandashti RV, Feizabadi MM, Teimourian S. The inhibitory effect of a Lactobacillus acidophilus derived biosurfactant on biofilm producer Serratia marcescens. Iran J Basic Med Sci. 2015; 18:1001–1007.
35. Sambanthamoorthy K, Feng X, Patel R, Patel S, Paranavitana C. Antimicrobial and antibiofilm potential of biosurfactants isolated from lactobacilli against multi-drug-resistant pathogens. BMC Microbiol. 2014; 14:197.
![crossref](/image/icon/bnr_ref_cross.gif)
36. Candela M, Perna F, Carnevali P, et al. Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production. Int J Food Microbiol. 2008; 125:286–292.
![crossref](/image/icon/bnr_ref_cross.gif)
37. Kim Y, Oh S, Kim SH. Released exopolysaccharide (r-EPS) produced from probiotic bacteria reduce biofilm formation of enterohemorrhagic Escherichia coli O157:H7. Biochem Biophys Res Commun. 2009; 379:324–329.
![crossref](/image/icon/bnr_ref_cross.gif)
38. Bernal P, Llamas MA. Promising biotechnological applications of antibiofilm exopolysaccharides. Microb Biotechnol. 2012; 5:670–673.
![crossref](/image/icon/bnr_ref_cross.gif)
39. Patel S, Majumder A, Goyal A. Potentials of exopolysaccharides from lactic acid bacteria. Indian J Microbiol. 2012; 52:3–12.
![crossref](/image/icon/bnr_ref_cross.gif)